UNSPSC 85285401: Diagnosis of drug-induced myopathy

This classification denotes the group of activities that yields a diagnosis of Drug-induced myopathy. Drug-induced myopathy is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as a four digit category under code G72. 0

UNSPSC 85285401 Diagnosis of drug-induced myopathy, a Commodity code, shows a significant mismatch between its nominal scope and the state and local contract activity tagged under it. The recent opportunities posted under this code do not involve diagnosis of drug-induced myopathy; instead, they span diagnostic imaging systems implementation, special education contracted services, and temporary health professional staffing. The code's narrow clinical specification does not align with the operational procurement documented in these notices, signaling that the taxonomy assignment may be incorrect or that state and local procurement offices are using the code as a catch-all for health services diagnostics work that extends well beyond drug-induced myopathy assessment.

The three most recent opportunities involve San Mateo Medical Center (SMMC) procuring a Picture Archiving and Communication System (PACS) with an RFP due October 21, 2026; Birdville Independent School District in northeast Tarrant County, Texas, soliciting special education contracted services (audiologist, diagnostician, dyslexia evaluator, speech language therapist, and other specialists) with proposals due October 21, 2026; and the County of Santa Clara Health System establishing a qualified vendor pool for temporary health professional staffing across 13 ancillary clinical categories including audiology, diagnostic imaging, and therapy services, with proposals due October 7, 2026. The issuing bodies represent a mix of county health systems and school districts. Geographic activity centers on California (San Mateo County and Santa Clara County) and Texas (Tarrant County). Given the scope mismatch, this code does not represent a reliable procurement signal for vendors targeting drug-induced myopathy diagnosis services in state and local markets.